Promise and challenges of traditional Chinese medicine, specifically Calculus bovis , in liver cancer treatment.

Autor:	Xu AX; School of Medicine, Nankai University, Tianjin 300071, China.; Department of General Surgery, The First Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100853, China.; Medical School of Chinese People's Liberation Army, Medical School of Chinese People's Liberation Army, Beijing 100853, China., Zhao ZF; Medical School of Chinese People's Liberation Army, Medical School of Chinese People's Liberation Army, Beijing 100853, China.; Department of Hepatobiliary and Pancreative Surgery, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing 100853, China., Zhu L; Department of General Surgery, The First Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100853, China., Zhang YH; Department of General Surgery, The First Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100853, China.; Medical School of Chinese People's Liberation Army, Medical School of Chinese People's Liberation Army, Beijing 100853, China., Li Y; Department of General Surgery, The First Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100853, China., Wei YF; School of Medicine, Nankai University, Tianjin 300071, China., Zhang BY; School of Medicine, Nankai University, Tianjin 300071, China., Jiang B; School of Medicine, Nankai University, Tianjin 300071, China. liujiayu@pku.edu.cn., Gao TZ; School of Medicine, Nankai University, Tianjin 300071, China., Li MS; Department of Surgery, Mancheng District People's Hospital, Baoding 072150, Hebei Province, China., Liu JY; Department of Neurosurgery, First Medical Centre of Chinese People's Liberation Army General Hospital, Beijing 100853, China. liujiayu@pku.edu.cn.
Jazyk:	angličtina
Zdroj:	World journal of gastroenterology [World J Gastroenterol] 2024 Oct 28; Vol. 30 (40), pp. 4380-4385.
DOI:	10.3748/wjg.v30.i40.4380
Abstrakt:	Liver cancer, one of the most common malignancies worldwide, ranks sixth in incidence and third in mortality. Liver cancer treatment options are diverse, including surgical resection, liver transplantation, percutaneous ablation, transarterial chemoembolization, radiotherapy, chemotherapy, targeted therapy, immunotherapy, and traditional Chinese medicine (TCM). A multidisciplinary team (MDT) is essential to customize treatment plans based on tumor staging, liver function, and performance status (PS), ensuring individualized patient care. Treatment decisions require a MDT to tailor strategies based on tumor staging, liver function, and PS, ensuring personalized care. The approval of new first-line and second-line drugs and the establishment of standard treatments based on immune checkpoint inhibitors have significantly expanded treatment options for advanced liver cancer, improving overall prognosis. However, many patients do not respond effectively to these treatments and ultimately succumb to the disease. Modern oncology treatments, while extending patient survival, often come with severe side effects, resistance, and damage to the body, negatively impacting quality of life. Huang et al 's study published at World Journal of Gastroenterology rigorously validates the anticancer properties of Calculus bovis , enhancing our understanding of TCM and contributing to new liver cancer treatment strategies. For over 5000 years, TCM has been used in East Asian countries like China to treat various diseases, including liver conditions. Analysis of real-world clinical data suggests that for patients with advanced-stage tumors lacking effective treatments, integrated TCM therapies could provide significant breakthroughs. Competing Interests: Conflict-of-interest statement: The authors declare that they have no competing interests. (©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu